...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Great surge in PPS for fellow RVX investers

KBC - Has there been any clairity around the tax issues of CVRs in the 7 years since the article you refer to was written?

tada 

Share
New Message
Please login to post a reply